On the heels of clinical failures for Nektar’s pegylated IL-2 candidate bempeg, Alkermes’ CEO argued its high-dose IL-2 for cancer is well differentiated during earnings call. Schizophrenia drug Lybalvi posted solid first full-quarter revenue, prescription numbers.

To accurately predict which patients will develop ileus following colorectal surgery, Entac Medical Inc. has created a self-contained, non-invasive disposable device that attaches to the abdomen. The device features a sensor to record bowel sounds and a microchip with an algorithm designed to detect a specific audio signature that is highly correlated to the development of postop ileus.

Infection Prevention Technologies LLC has designed a new generation of hospital disinfection robots that emit germicidal ultraviolet light to destroy the DNA of cells found in infectious pathogens.

Biolectrics LLC has developed a home-use dental mouth guard that emits undetectable low levels of electrical stimulation to promote healing of periodontal disease by destroying bacteria.